Evidence map›Paper›PMID 31091659›Full record

ArticleInternational journal of molecular sciences2019

Curcumin Treatment in Combination with Glucose Restriction Inhibits Intracellular Alkalinization and Tumor Growth in Hepatoma Cells.

So Won Kim, Min-Ji Cha, Seul-Ki Lee, Byeong-Wook Song, Xinghai Jin, Jae Myun Lee, Jeon Han Park, Jong Doo Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Exosome-like nanoparticles derived fromInternational journal of pharmaceutics: X · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Effects of Obesity and Calorie Restriction on Cancer Development.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Pathophysiology of hepatic NaExperimental and therapeutic medicine · 2020
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

So Won KimDepartment of Pharmacology, Catholic Kwandong University College of Medicine, Gangneung 25601, Korea. kswlab2015@gmail.com.
Min-Ji ChaInstitute for Translational and Clinical Research, Catholic Kwandong University International St. Mary's Hospital, Incheon 22711, Korea. minjicha619@gmail.com.
Seul-Ki LeeKANT Science Research Institute, Incheon 22711, Korea. seulki1011@nate.com.
Byeong-Wook SongDepartment of Medical Science, Catholic Kwandong University College of Medicine, Gangneung 25601, Korea. songbw@gmail.com.ORCID 0000-0002-9962-0941
Xinghai JinKANT Science Research Institute, Incheon 22711, Korea. jxh630@gmail.com.
Jae Myun LeeBrain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul 03722, Korea. jaemyun@yuhs.ac.
Jeon Han ParkDepartment of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul 03722, Korea. jhpark5277@yuhs.ac.
Jong Doo LeeInstitute for Translational and Clinical Research, Catholic Kwandong University International St. Mary's Hospital, Incheon 22711, Korea. jdlee@yuhs.ac.
Yonsei University · KRCatholic Kwandong University · KRCatholic Kwandong University International St. Mary's Hospital · KR

Funding

National Research Foundation of Korea 2013-31-0342
6 · The paper itself

Abstract

Dysregulation of cellular energy metabolism is closely linked to cancer development and progression. Calorie or glucose restriction (CR or GR) inhibits energy-dependent pathways, including IGF-1/PI3K/Akt/mTOR, in cancer cells. However, alterations in proton dynamics and reversal of the pH gradient across the cell membrane, which results in intracellular alkalinization and extracellular acidification in cancer tissues, have emerged as important etiopathogenic factors. We measured glucose, lactate, and ATP production after GR, plant-derived CR-mimetic curcumin treatment, and curcumin plus GR in human hepatoma cells. Intracellular pH regulatory effects, in particular, protein-protein interactions within mTOR complex-1 and its structural change, were investigated. Curcumin treatment or GR mildly inhibited Na+/H+ exchanger-1 (NHE1). vATPase, monocarboxylate transporter (MCT)-1, and MCT4 level. Combination treatment with curcumin and GR further enhanced the inhibitory effects on these transporters and proton-extruding enzymes, with intracellular pH reduction. ATP and lactate production decreased according to pH change. Modeling of mTOR protein revealed structural changes upon treatments, and curcumin plus GR decreased binding of Raptor and GβL to mTOR, as well as of Rag A and Rag B to Raptor. Consequently, 4EBP1 phosphorylation was decreased and cell migration and proliferation were inhibited in a pH-dependent manner. Autophagy was increased by curcumin plus GR. In conclusion, curcumin treatment combined with GR may be a useful supportive approach for preventing intracellular alkalinization and cancer progression.

Indexed as

AlkaliesAntineoplastic AgentsCarcinoma, HepatocellularCell LineCell ProliferationCurcuminGlucoseHep G2 CellsHumansLiver NeoplasmsMonocarboxylic Acid TransportersRegulatory-Associated Protein of mTORVacuolar Proton-Translocating ATPasesAlkaliesAntineoplastic AgentsCurcuminGlucoseMonocarboxylic Acid TransportersRegulatory-Associated Protein of mTORVacuolar Proton-Translocating ATPasescurcuminglucose restrictionhepatomaintracellular pHtumor suppression

Identifiers

PMID31091659
PMCPMC6566721
OpenAlexW2945329871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.